Curis
CRIS
#11244
Rank
โ‚ฌ1.3 M
Marketcap
0,54ย โ‚ฌ
Share price
9.39%
Change (1 day)
-58.33%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2026 (TTM): -โ‚ฌ7.6 Million

According to Curis's latest financial reports the company's current earnings are โ‚ฌ4.31 Million. In 2025 the company made an earning of -โ‚ฌ4.83 Million, an increase over its 2024 earnings that were of -โ‚ฌ38.25 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ7.6 Million57.3%
2025 -โ‚ฌ4.83 Million-87.38%
2024 -โ‚ฌ38.25 Million-5.77%
2023 -โ‚ฌ40.6 Million-13.1%
2022 -โ‚ฌ46.72 Million27.52%
2021 -โ‚ฌ36.64 Million65.09%
2020 -โ‚ฌ22.19 Million-9.1%
2019 -โ‚ฌ24.41 Million-4.73%
2018 -โ‚ฌ25.62 Million-41.95%
2017 -โ‚ฌ44.14 Million-14.37%
2016 -โ‚ฌ51.54 Million3.55%
2015 -โ‚ฌ49.77 Million271.52%
2014 -โ‚ฌ13.4 Million76.64%
2013 -โ‚ฌ7.59 Million
2011 -โ‚ฌ6.45 Million27.76%
2010 -โ‚ฌ5.05 Million-43.87%
2009 -โ‚ฌ8.99 Million-23.44%
2008 -โ‚ฌ11.74 Million56.66%
2007 -โ‚ฌ7.49 Million-16.71%
2006 -โ‚ฌ9 Million-36.92%
2005 -โ‚ฌ14.26 Million156.25%
2004 -โ‚ฌ5.57 Million-37.24%
2003 -โ‚ฌ8.87 Million-93.34%
2002 -โ‚ฌ0.14 Billion86.79%
2001 -โ‚ฌ71.25 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚ฌ6.17 B-81,859.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ10.65 B-141,080.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-โ‚ฌ55.34 Million 632.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚ฌ0.92 B-12,356.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚ฌ0.3 Billion 3,756.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-โ‚ฌ19.91 Million 163.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-โ‚ฌ85.05 Million 1,025.71%๐Ÿ‡บ๐Ÿ‡ธ USA